Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-03-24 to 2022-03-24
Current total value of award: $2017.18
Description: 4556674523!HYDROXYZINE HCL INJ